Computational Drug Discovery Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: CB9874FE857EEN
Market Monitor Global

Abstracts

Computational Drug Discovery/Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved.

This report contains market size and forecasts of Computational Drug Discovery in Global, including the following market information:

Global Computational Drug Discovery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Computational Drug Discovery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Structure-based Drug Design (SBDD) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Computational Drug Discovery include AMRI, Charles River, Schr?dinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro and BOC Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Computational Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Computational Drug Discovery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Computational Drug Discovery Market Segment Percentages, by Type, 2021 (%)

• Structure-based Drug Design (SBDD)
• Ligand-based Drug Design (LBDD)
• Sequence-based Approaches

Global Computational Drug Discovery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Computational Drug Discovery Market Segment Percentages, by Application, 2021 (%)

• Oncological Disorders
• Neurological Disorders
• Immunological Disorders
• Infectious Diseases
• Others

Global Computational Drug Discovery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Computational Drug Discovery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Computational Drug Discovery revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Computational Drug Discovery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AMRI
• Charles River
• Schr?dinger
• Evotec
• Bayers
• GVK Biosciences
• AstraZeneca
• BioDuro
• BOC Sciences
• Aris Pharmaceuticals
• ChemDiv
• RTI International
• XRQTC
• Pharmaron

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Computational Drug Discovery Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Computational Drug Discovery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COMPUTATIONAL DRUG DISCOVERY OVERALL MARKET SIZE

2.1 Global Computational Drug Discovery Market Size: 2021 VS 2028
2.2 Global Computational Drug Discovery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Computational Drug Discovery Players in Global Market
3.2 Top Global Computational Drug Discovery Companies Ranked by Revenue
3.3 Global Computational Drug Discovery Revenue by Companies
3.4 Top 3 and Top 5 Computational Drug Discovery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Computational Drug Discovery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Computational Drug Discovery Players in Global Market
  3.6.1 List of Global Tier 1 Computational Drug Discovery Companies
  3.6.2 List of Global Tier 2 and Tier 3 Computational Drug Discovery Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Computational Drug Discovery Market Size Markets, 2021 & 2028
  4.1.2 Structure-based Drug Design (SBDD)
  4.1.3 Ligand-based Drug Design (LBDD)
  4.1.4 Sequence-based Approaches
4.2 By Type - Global Computational Drug Discovery Revenue & Forecasts
  4.2.1 By Type - Global Computational Drug Discovery Revenue, 2017-2022
  4.2.2 By Type - Global Computational Drug Discovery Revenue, 2023-2028
  4.2.3 By Type - Global Computational Drug Discovery Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Computational Drug Discovery Market Size, 2021 & 2028
  5.1.2 Oncological Disorders
  5.1.3 Neurological Disorders
  5.1.4 Immunological Disorders
  5.1.5 Infectious Diseases
  5.1.6 Others
5.2 By Application - Global Computational Drug Discovery Revenue & Forecasts
  5.2.1 By Application - Global Computational Drug Discovery Revenue, 2017-2022
  5.2.2 By Application - Global Computational Drug Discovery Revenue, 2023-2028
  5.2.3 By Application - Global Computational Drug Discovery Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Computational Drug Discovery Market Size, 2021 & 2028
6.2 By Region - Global Computational Drug Discovery Revenue & Forecasts
  6.2.1 By Region - Global Computational Drug Discovery Revenue, 2017-2022
  6.2.2 By Region - Global Computational Drug Discovery Revenue, 2023-2028
  6.2.3 By Region - Global Computational Drug Discovery Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Computational Drug Discovery Revenue, 2017-2028
  6.3.2 US Computational Drug Discovery Market Size, 2017-2028
  6.3.3 Canada Computational Drug Discovery Market Size, 2017-2028
  6.3.4 Mexico Computational Drug Discovery Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Computational Drug Discovery Revenue, 2017-2028
  6.4.2 Germany Computational Drug Discovery Market Size, 2017-2028
  6.4.3 France Computational Drug Discovery Market Size, 2017-2028
  6.4.4 U.K. Computational Drug Discovery Market Size, 2017-2028
  6.4.5 Italy Computational Drug Discovery Market Size, 2017-2028
  6.4.6 Russia Computational Drug Discovery Market Size, 2017-2028
  6.4.7 Nordic Countries Computational Drug Discovery Market Size, 2017-2028
  6.4.8 Benelux Computational Drug Discovery Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Computational Drug Discovery Revenue, 2017-2028
  6.5.2 China Computational Drug Discovery Market Size, 2017-2028
  6.5.3 Japan Computational Drug Discovery Market Size, 2017-2028
  6.5.4 South Korea Computational Drug Discovery Market Size, 2017-2028
  6.5.5 Southeast Asia Computational Drug Discovery Market Size, 2017-2028
  6.5.6 India Computational Drug Discovery Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Computational Drug Discovery Revenue, 2017-2028
  6.6.2 Brazil Computational Drug Discovery Market Size, 2017-2028
  6.6.3 Argentina Computational Drug Discovery Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Computational Drug Discovery Revenue, 2017-2028
  6.7.2 Turkey Computational Drug Discovery Market Size, 2017-2028
  6.7.3 Israel Computational Drug Discovery Market Size, 2017-2028
  6.7.4 Saudi Arabia Computational Drug Discovery Market Size, 2017-2028
  6.7.5 UAE Computational Drug Discovery Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AMRI
  7.1.1 AMRI Corporate Summary
  7.1.2 AMRI Business Overview
  7.1.3 AMRI Computational Drug Discovery Major Product Offerings
  7.1.4 AMRI Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.1.5 AMRI Key News
7.2 Charles River
  7.2.1 Charles River Corporate Summary
  7.2.2 Charles River Business Overview
  7.2.3 Charles River Computational Drug Discovery Major Product Offerings
  7.2.4 Charles River Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.2.5 Charles River Key News
7.3 Schr?dinger
  7.3.1 Schr?dinger Corporate Summary
  7.3.2 Schr?dinger Business Overview
  7.3.3 Schr?dinger Computational Drug Discovery Major Product Offerings
  7.3.4 Schr?dinger Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.3.5 Schr?dinger Key News
7.4 Evotec
  7.4.1 Evotec Corporate Summary
  7.4.2 Evotec Business Overview
  7.4.3 Evotec Computational Drug Discovery Major Product Offerings
  7.4.4 Evotec Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.4.5 Evotec Key News
7.5 Bayers
  7.5.1 Bayers Corporate Summary
  7.5.2 Bayers Business Overview
  7.5.3 Bayers Computational Drug Discovery Major Product Offerings
  7.5.4 Bayers Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.5.5 Bayers Key News
7.6 GVK Biosciences
  7.6.1 GVK Biosciences Corporate Summary
  7.6.2 GVK Biosciences Business Overview
  7.6.3 GVK Biosciences Computational Drug Discovery Major Product Offerings
  7.6.4 GVK Biosciences Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.6.5 GVK Biosciences Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Computational Drug Discovery Major Product Offerings
  7.7.4 AstraZeneca Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 BioDuro
  7.8.1 BioDuro Corporate Summary
  7.8.2 BioDuro Business Overview
  7.8.3 BioDuro Computational Drug Discovery Major Product Offerings
  7.8.4 BioDuro Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.8.5 BioDuro Key News
7.9 BOC Sciences
  7.9.1 BOC Sciences Corporate Summary
  7.9.2 BOC Sciences Business Overview
  7.9.3 BOC Sciences Computational Drug Discovery Major Product Offerings
  7.9.4 BOC Sciences Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.9.5 BOC Sciences Key News
7.10 Aris Pharmaceuticals
  7.10.1 Aris Pharmaceuticals Corporate Summary
  7.10.2 Aris Pharmaceuticals Business Overview
  7.10.3 Aris Pharmaceuticals Computational Drug Discovery Major Product Offerings
  7.10.4 Aris Pharmaceuticals Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.10.5 Aris Pharmaceuticals Key News
7.11 ChemDiv
  7.11.1 ChemDiv Corporate Summary
  7.11.2 ChemDiv Business Overview
  7.11.3 ChemDiv Computational Drug Discovery Major Product Offerings
  7.11.4 ChemDiv Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.11.5 ChemDiv Key News
7.12 RTI International
  7.12.1 RTI International Corporate Summary
  7.12.2 RTI International Business Overview
  7.12.3 RTI International Computational Drug Discovery Major Product Offerings
  7.12.4 RTI International Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.12.5 RTI International Key News
7.13 XRQTC
  7.13.1 XRQTC Corporate Summary
  7.13.2 XRQTC Business Overview
  7.13.3 XRQTC Computational Drug Discovery Major Product Offerings
  7.13.4 XRQTC Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.13.5 XRQTC Key News
7.14 Pharmaron
  7.14.1 Pharmaron Corporate Summary
  7.14.2 Pharmaron Business Overview
  7.14.3 Pharmaron Computational Drug Discovery Major Product Offerings
  7.14.4 Pharmaron Computational Drug Discovery Revenue in Global Market (2017-2022)
  7.14.5 Pharmaron Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Computational Drug Discovery Market Opportunities & Trends in Global Market
Table 2. Computational Drug Discovery Market Drivers in Global Market
Table 3. Computational Drug Discovery Market Restraints in Global Market
Table 4. Key Players of Computational Drug Discovery in Global Market
Table 5. Top Computational Drug Discovery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Computational Drug Discovery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Computational Drug Discovery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Computational Drug Discovery Product Type
Table 9. List of Global Tier 1 Computational Drug Discovery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Computational Drug Discovery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Computational Drug Discovery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Computational Drug Discovery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Computational Drug Discovery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Computational Drug Discovery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Computational Drug Discovery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Computational Drug Discovery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Computational Drug Discovery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Computational Drug Discovery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Computational Drug Discovery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Computational Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Computational Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Computational Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Computational Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Computational Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Computational Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Computational Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Computational Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Computational Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Computational Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 30. AMRI Corporate Summary
Table 31. AMRI Computational Drug Discovery Product Offerings
Table 32. AMRI Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 33. Charles River Corporate Summary
Table 34. Charles River Computational Drug Discovery Product Offerings
Table 35. Charles River Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 36. Schr?dinger Corporate Summary
Table 37. Schr?dinger Computational Drug Discovery Product Offerings
Table 38. Schr?dinger Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 39. Evotec Corporate Summary
Table 40. Evotec Computational Drug Discovery Product Offerings
Table 41. Evotec Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 42. Bayers Corporate Summary
Table 43. Bayers Computational Drug Discovery Product Offerings
Table 44. Bayers Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 45. GVK Biosciences Corporate Summary
Table 46. GVK Biosciences Computational Drug Discovery Product Offerings
Table 47. GVK Biosciences Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Computational Drug Discovery Product Offerings
Table 50. AstraZeneca Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 51. BioDuro Corporate Summary
Table 52. BioDuro Computational Drug Discovery Product Offerings
Table 53. BioDuro Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 54. BOC Sciences Corporate Summary
Table 55. BOC Sciences Computational Drug Discovery Product Offerings
Table 56. BOC Sciences Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 57. Aris Pharmaceuticals Corporate Summary
Table 58. Aris Pharmaceuticals Computational Drug Discovery Product Offerings
Table 59. Aris Pharmaceuticals Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 60. ChemDiv Corporate Summary
Table 61. ChemDiv Computational Drug Discovery Product Offerings
Table 62. ChemDiv Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 63. RTI International Corporate Summary
Table 64. RTI International Computational Drug Discovery Product Offerings
Table 65. RTI International Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 66. XRQTC Corporate Summary
Table 67. XRQTC Computational Drug Discovery Product Offerings
Table 68. XRQTC Computational Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 69. Pharmaron Corporate Summary
Table 70. Pharmaron Computational Drug Discovery Product Offerings
Table 71. Pharmaron Computational Drug Discovery Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Computational Drug Discovery Segment by Type in 2021
Figure 2. Computational Drug Discovery Segment by Application in 2021
Figure 3. Global Computational Drug Discovery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Computational Drug Discovery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Computational Drug Discovery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Computational Drug Discovery Revenue in 2021
Figure 8. By Type - Global Computational Drug Discovery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Computational Drug Discovery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Computational Drug Discovery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Computational Drug Discovery Revenue Market Share, 2017-2028
Figure 12. US Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Computational Drug Discovery Revenue Market Share, 2017-2028
Figure 16. Germany Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 17. France Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Computational Drug Discovery Revenue Market Share, 2017-2028
Figure 24. China Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 28. India Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Computational Drug Discovery Revenue Market Share, 2017-2028
Figure 30. Brazil Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Computational Drug Discovery Revenue Market Share, 2017-2028
Figure 33. Turkey Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Computational Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 37. AMRI Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Charles River Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Schr?dinger Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Evotec Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayers Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GVK Biosciences Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BioDuro Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BOC Sciences Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aris Pharmaceuticals Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ChemDiv Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. RTI International Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. XRQTC Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pharmaron Computational Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)